Sun Pharmaceutical Industries Limited — Important, 04-11-2024: General Updates

Sun Pharmaceutical Industries reported a strong Q2 FY25 with sales of Rs. 132,642 million, reflecting a 10.5% year-over-year growth. Net profit rose by 28% to Rs. 30,402 million, with an EPS of Rs. 12.7. Significant contributions came from U.S. sales, which increased by 20.3%, and the company's expanding specialty pipeline, including new product launches. Additionally, net cash stands at $2.6 billion, highlighting the company’s solid financial position. Further updates are available on their website.